Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Veterinary Pharmacology and Toxicology

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1620161

This article is part of the Research TopicAlternatives to Antibiotics in Food Animals: Exploring Natural and Synthetic InterventionsView all 5 articles

The kinetic behavior of matrine in pig intestinal lumen after oral administration and its physiologically based pharmacokinetic modeling

Provisionally accepted
Bo  YangBo Yang1YiWei  JiaYiWei Jia1FuHao  WangFuHao Wang1XiaoLing  LvXiaoLing Lv2SuYang  MaSuYang Ma1YaXin  TanYaXin Tan1WanXin  ZhangWanXin Zhang1Dan  WanDan Wan3Rui  LiRui Li3DanNa  ZhouDanNa Zhou4*DaoJin  YuDaoJin Yu1*
  • 1Fujian Key Laboratory of Traditional Chinese Veterinary Medicine and Animal Health, College of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, China
  • 2Fujian Sunner Development Co. Ltd, Nanping, China
  • 3Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, China
  • 4Hubei Provincial Key Laboratory of Animal Pathogenic Microbiology, Institute of Animal Husbandry and Veterinary, Wuhan, China

The final, formatted version of the article will be published soon.

Matrine (MT) has been found to restore the susceptibility of Escherichia coli to a variety of antibiotics in vitro. Nevertheless, the absence of pharmacokinetic data makes it uncertain whether MT exhibits efficacy in vivo. The study aimed to investigate the kinetic behavior of MT in pig intestinal lumen, the primary site for the colonization of enterotoxigenic Escherichia coli, and to develop a minimal physiologically based pharmacokinetic (PBPK) model for MT in pig intestinal lumen. Two animal experiments were carried out for these purposes. In experiment 1, twelve pigs were implanted with a sterile T-cannula, and then were given a single oral dose of MT or MT-Amoxicillin (AMO) combination at 40 or 70 mg/kg. In experiment 2, twenty-five pigs were administered with MT at 50 mg/kg/d by oral gavage for 5 d. Intestinal contents were collected at predetermined times and analysed by liquid chromatography tandem mass spectrometry (LC-MS/MS) method. The concentration-time data were analysed by non-compartmental method. Subsequently, a four-compartment PBPK model was developed and validated. After oral administrations, the MT concentrations in pig intestinal lumen increased rapidly and reached their peaks within 2 h, then decreased in a two-phase decay pattern. The co-administered AMO did not alter the kinetic behavior of MT in pig intestinal lumen. The PBPK model gave an accurate prediction of MT concentrations in pig intestinal lumen at most time points. A dosage regimen of 70 mg/kg every 8 h was recommended to ensure a sufficient drug exposure.

Keywords: physiologically based pharmacokinetic model, matrine, pig intestinal lumen, Pharmacodynamic evaluation, Liquid chromatography tandem mass spectrometry

Received: 29 Apr 2025; Accepted: 29 Sep 2025.

Copyright: © 2025 Yang, Jia, Wang, Lv, Ma, Tan, Zhang, Wan, Li, Zhou and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
DanNa Zhou, zdn66@hbaas.com
DaoJin Yu, 364369723@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.